Response to Tacrine in Patients with Dementia of the Alzheimer's Type: Cerebral Perfusion Change is Related to Change in Mental Status

References

• Ahlin A., Adem A., Junthe T., Ohman G., Nyback H. Pharmacokinetics of tetrahydroaminoacridine: Relation to clinical and biochemical effects in Alzheimer patients. International Journal of Clinical Psychopharmacology 1992; 7: 29–36
   PubMedGoogle Scholar
• Bonte F. J., Hom J., Tintner R., Weiner M. F. Single photon tomography in Alzheimer's disease and the dementias. Seminars in Nuclear Medicine 1990; 20: 342–352
   PubMedGoogle Scholar
• Chatellier G., Lacomblez I. Tacrine (tetrahydroaminoacridine; THA) and lecithin in senile dementia of the Alzheimer type: a multicentre trial (Groupe Francais d'Etude de la Tetrahydoraminoacridine). British Medical Journal 1990; 300: 495–499
   PubMed Web of Science ®Google Scholar
• Davies B., Andrewes D., Stargatt R., Ames D., Tuckwell V., Davis S. Tacrine in Alzheimer's disease (letter). Lancet 1989; 2: 163–164
   PubMedGoogle Scholar
• Davis K. L., Thal L. J., Gamzu E. R., Davis C. S., Woolson R. F., Gracon S. L., Drachman D. A., Schneider L. S., Whitehouse P. J., Hoover T. M. A double-blind, placebo-controlled multicenter study of tacrine for Alzheimer's disease. The Tacrine Collaborative Study group. The New England Journal of Medicine 1992; 327: 1253–1259
   PubMed Web of Science ®Google Scholar
• Evans D. A., Funkenstein H. H., Albert M. S., Scherr P. A., Cook N. R., Chown M. J., Hebert L. E., Hennekens C. H., Taylor J. O. Prevalence of Alzheimer's disease in a community of older persons. Higher than previously reported. Journal of the Americal Medical Association 1989; 262: 2551–2556
   PubMed Web of Science ®Google Scholar
• Farlow M, Gracon S. I., Hershey L. A., Lewis K. W., Sadowsky C. H., Dolan-Ureno J. A controlled trial of tacrine in Alzheimer's disease. The Tacrine Study Group. Journal of the American Medical Association 1992; 268: 2523–2529
   PubMed Web of Science ®Google Scholar
• Folstein M. F., Folstein S. E., McHugh P. R. Mini-Mental State: A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research 1975; 12: 189–198
   PubMed Web of Science ®Google Scholar
• Gauthier S., Bouchard R., Lamontagne A., Bailey P., Bergman H., Ratner J., Tesfaye Y., Saint-Martin M., Bacher Y., Carrier L. Tetrahydroaminoacridine-lecithin combination treatment in patients with intermediate-stage Alzheimer's disease. Results of a Canadian double-blind, crossover, multicenter study. The New England Journal of Medicine. 1990; 322: 1272–1276
   PubMed Web of Science ®Google Scholar
• Geaney D. P., Abou-Saleh M. T. The use and applications of single-photon emission computerised tomography in dementia. British Journal of Psychiatry 1990; 9: 66–75, (Suppl)
   Google Scholar
• Green D. M., Swets J. A. Signal Detection Theory and Psychophysics. Wiley, New York 1966
   Google Scholar
• Kaye W. H., Sitaram N., Weingartner H., Ebert M. H., Smallberg S., Gilin J. C. Modest facilitation of memory in dementia with combined lecithin and anticholinerestase treatment. Biological Psychiatry 1982; 17: 275–280
   PubMedGoogle Scholar
• McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E. M. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34: 939–944
   PubMed Web of Science ®Google Scholar
• Minthon L., Gustafson L., Dalfelt G., Hagberg B., Nilsson K., Risberg J., Rosen I., Seiving B., Wendt P. E. Oral tetrahydroaminoacridine treatment of Alzheimer's disease evaluated clinically and by regional cerebral blood flow and EEG. Dementia 1993; 4: 32–42
   PubMedGoogle Scholar
• Molloy D. W., Guyatt G. H., Wilson D. B., Duke R., Rees L., Singer J. Effect of tetrahydroaminoacridine on cognition, function and behavior in Alzheimer's disease. Canadian Medical Association Journal 1991; 144: 29–34
   PubMed Web of Science ®Google Scholar
• Mortimer J. A., Ebbitt B., Jun S. P., Finch M. D. Predictors of cognitive and functional progression in patients with probable Alzheimer's disease. Neurology 1992; 42: 1689–1696
   PubMed Web of Science ®Google Scholar
• Nordberg A., Lilja A., Lundqvist H., Hartvig P., Amberla K., Viitanen M., Warpman U., Johansson M., Hellstrom-Lindahl E., Bjurling P. Tacrine restores cholinergic nicotinic receptors and glucose metabolism in Alzheimer patients as visualized by positron emission tomography. Neurobiology of Aging 1992; 13: 747–758
   PubMed Web of Science ®Google Scholar
• O'Brien J. T., Eagger S., Syed G. M., Sahakian B. J., Levy R. A study of regional cerebral blood flow and cognitive performance in Alzheimer's disease. Journal of Neurology, Neurosurgery, and Psychiatry 1992; 55: 1182–1187
   PubMed Web of Science ®Google Scholar
• Rosen W. G., Terry R. D., Fuld P. A., Katzman R., Peck A. Pathological verification of ischemic score in differentiation of dementias. Annals of Neurology 1980; 7: 486–488
   PubMed Web of Science ®Google Scholar
• Siegel S. Nonparametric Statistics for the Behavioral Sciences. McGraw-Hill, New York 1956
   Google Scholar
• Skoog I., Nilsson L., Palmertz B., Andreasson L. A., Svanborg A. A population-based study of dementia in 85-year-olds. The New England Journal of Medicine 1993; 328: 153–158
   PubMed Web of Science ®Google Scholar
• Summers W. K., Majovski L. V., Marsh G. M., Tachiki K., Kling A. Oral tetrahydroaminoacridine in long-term treatment of senile dementia, Alzheimer type. The New England Journal of Medicine 1986; 315: 1241–1245
   PubMed Web of Science ®Google Scholar